HEADER TRANSFERASE/TRANSFERASE INHIBITOR 07-FEB-13 4J53 TITLE CRYSTAL STRUCTURE OF PLK1 IN COMPLEX WITH TAK-960 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PLK1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN (UNP RESIDUES 38-330); COMPND 5 SYNONYM: POLO-LIKE KINASE 1, PLK-1, SERINE/THREONINE-PROTEIN KINASE COMPND 6 13, STPK13; COMPND 7 EC: 2.7.11.21; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PLK1, PLK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS PROTEIN SERINE/THREONINE KINASE, MITOSIS, ONCOGENESIS, REGULATION OF KEYWDS 2 CELL CYCLE, KINASE DOMAIN, ATP BINDING, NUCLEAR, TRANSFERASE- KEYWDS 3 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.J.HOSFIELD,R.J.SKENE REVDAT 4 28-FEB-24 4J53 1 REMARK SEQADV LINK REVDAT 3 15-NOV-17 4J53 1 REMARK REVDAT 2 05-JUN-13 4J53 1 JRNL REVDAT 1 29-MAY-13 4J53 0 JRNL AUTH Z.NIE,V.FEHER,S.NATALA,C.MCBRIDE,A.KIRYANOV,B.JONES,B.LAM, JRNL AUTH 2 Y.LIU,S.KALDOR,J.STAFFORD,K.HIKAMI,N.UCHIYAMA,T.KAWAMOTO, JRNL AUTH 3 Y.HIKICHI,S.MATSUMOTO,N.AMANO,L.ZHANG,D.HOSFIELD,R.SKENE, JRNL AUTH 4 H.ZOU,X.CAO,T.ICHIKAWA JRNL TITL DISCOVERY OF TAK-960: AN ORALLY AVAILABLE SMALL MOLECULE JRNL TITL 2 INHIBITOR OF POLO-LIKE KINASE 1 (PLK1). JRNL REF BIOORG.MED.CHEM.LETT. V. 23 3662 2013 JRNL REFN ISSN 0960-894X JRNL PMID 23664874 JRNL DOI 10.1016/J.BMCL.2013.02.083 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.35 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.3 REMARK 3 NUMBER OF REFLECTIONS : 13074 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 650 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.57 REMARK 3 REFLECTION IN BIN (WORKING SET) : 527 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 52.84 REMARK 3 BIN R VALUE (WORKING SET) : 0.2310 REMARK 3 BIN FREE R VALUE SET COUNT : 32 REMARK 3 BIN FREE R VALUE : 0.2910 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2374 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 45 REMARK 3 SOLVENT ATOMS : 130 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.02 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.13000 REMARK 3 B22 (A**2) : -0.13000 REMARK 3 B33 (A**2) : 0.20000 REMARK 3 B12 (A**2) : -0.07000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.507 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.286 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.211 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 22.189 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.920 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2481 ; 0.007 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2449 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3352 ; 1.208 ; 2.001 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5642 ; 0.715 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 292 ; 5.837 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 110 ;35.964 ;22.455 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 451 ;16.794 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 23 ;14.664 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 368 ; 0.065 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2708 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 570 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 38 A 330 REMARK 3 RESIDUE RANGE : A 401 A 403 REMARK 3 RESIDUE RANGE : A 501 A 630 REMARK 3 ORIGIN FOR THE GROUP (A): 39.7284 23.0345 35.3266 REMARK 3 T TENSOR REMARK 3 T11: 0.0106 T22: 0.1468 REMARK 3 T33: 0.1025 T12: -0.0046 REMARK 3 T13: -0.0056 T23: 0.0171 REMARK 3 L TENSOR REMARK 3 L11: 1.2113 L22: 1.4620 REMARK 3 L33: 4.1248 L12: 0.1477 REMARK 3 L13: -0.3642 L23: -0.6453 REMARK 3 S TENSOR REMARK 3 S11: -0.0983 S12: -0.0241 S13: 0.0219 REMARK 3 S21: -0.0440 S22: 0.0231 S23: 0.0056 REMARK 3 S31: 0.1094 S32: 0.0446 S33: 0.0752 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 3 U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 4J53 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-FEB-13. REMARK 100 THE DEPOSITION ID IS D_1000077606. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-MAY-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13095 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.2 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.57 REMARK 200 COMPLETENESS FOR SHELL (%) : 53.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 0.22400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.92 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.95 MM SUCCINIC ACID, 1.7% PEG2000 REMARK 280 MME, 0.4 MM ZINC ACETATE, 100 MM HEPES, PH 7.0, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 102.64000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 51.32000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 51.32000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 102.64000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 136 -135.56 67.92 REMARK 500 LYS A 146 -125.01 52.93 REMARK 500 ASP A 176 45.29 -148.82 REMARK 500 ASP A 194 85.29 44.41 REMARK 500 LYS A 225 47.91 82.81 REMARK 500 SER A 229 -135.40 -153.72 REMARK 500 LEU A 286 55.61 -101.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 93 NE2 REMARK 620 2 CYS A 212 SG 110.4 REMARK 620 3 HOH A 526 O 97.6 83.4 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1J4 A 403 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4J52 RELATED DB: PDB DBREF 4J53 A 38 330 UNP P53350 PLK1_HUMAN 38 330 SEQADV 4J53 VAL A 210 UNP P53350 THR 210 ENGINEERED MUTATION SEQRES 1 A 293 LYS GLU ILE PRO GLU VAL LEU VAL ASP PRO ARG SER ARG SEQRES 2 A 293 ARG ARG TYR VAL ARG GLY ARG PHE LEU GLY LYS GLY GLY SEQRES 3 A 293 PHE ALA LYS CYS PHE GLU ILE SER ASP ALA ASP THR LYS SEQRES 4 A 293 GLU VAL PHE ALA GLY LYS ILE VAL PRO LYS SER LEU LEU SEQRES 5 A 293 LEU LYS PRO HIS GLN ARG GLU LYS MET SER MET GLU ILE SEQRES 6 A 293 SER ILE HIS ARG SER LEU ALA HIS GLN HIS VAL VAL GLY SEQRES 7 A 293 PHE HIS GLY PHE PHE GLU ASP ASN ASP PHE VAL PHE VAL SEQRES 8 A 293 VAL LEU GLU LEU CYS ARG ARG ARG SER LEU LEU GLU LEU SEQRES 9 A 293 HIS LYS ARG ARG LYS ALA LEU THR GLU PRO GLU ALA ARG SEQRES 10 A 293 TYR TYR LEU ARG GLN ILE VAL LEU GLY CYS GLN TYR LEU SEQRES 11 A 293 HIS ARG ASN ARG VAL ILE HIS ARG ASP LEU LYS LEU GLY SEQRES 12 A 293 ASN LEU PHE LEU ASN GLU ASP LEU GLU VAL LYS ILE GLY SEQRES 13 A 293 ASP PHE GLY LEU ALA THR LYS VAL GLU TYR ASP GLY GLU SEQRES 14 A 293 ARG LYS LYS VAL LEU CYS GLY THR PRO ASN TYR ILE ALA SEQRES 15 A 293 PRO GLU VAL LEU SER LYS LYS GLY HIS SER PHE GLU VAL SEQRES 16 A 293 ASP VAL TRP SER ILE GLY CYS ILE MET TYR THR LEU LEU SEQRES 17 A 293 VAL GLY LYS PRO PRO PHE GLU THR SER CYS LEU LYS GLU SEQRES 18 A 293 THR TYR LEU ARG ILE LYS LYS ASN GLU TYR SER ILE PRO SEQRES 19 A 293 LYS HIS ILE ASN PRO VAL ALA ALA SER LEU ILE GLN LYS SEQRES 20 A 293 MET LEU GLN THR ASP PRO THR ALA ARG PRO THR ILE ASN SEQRES 21 A 293 GLU LEU LEU ASN ASP GLU PHE PHE THR SER GLY TYR ILE SEQRES 22 A 293 PRO ALA ARG LEU PRO ILE THR CYS LEU THR ILE PRO PRO SEQRES 23 A 293 ARG PHE SER ILE ALA PRO SER HET ZN A 401 1 HET ACT A 402 4 HET 1J4 A 403 40 HETNAM ZN ZINC ION HETNAM ACT ACETATE ION HETNAM 1J4 4-[(9-CYCLOPENTYL-7,7-DIFLUORO-5-METHYL-6-OXO-6,7,8,9- HETNAM 2 1J4 TETRAHYDRO-5H-PYRIMIDO[4,5-B][1,4]DIAZEPIN-2-YL) HETNAM 3 1J4 AMINO]-2-FLUORO-5-METHOXY-N-(1-METHYLPIPERIDIN-4-YL) HETNAM 4 1J4 BENZAMIDE FORMUL 2 ZN ZN 2+ FORMUL 3 ACT C2 H3 O2 1- FORMUL 4 1J4 C27 H34 F3 N7 O3 FORMUL 5 HOH *130(H2 O) HELIX 1 1 SER A 87 LEU A 89 5 3 HELIX 2 2 LYS A 91 SER A 107 1 17 HELIX 3 3 SER A 137 LYS A 146 1 10 HELIX 4 4 THR A 149 ASN A 170 1 22 HELIX 5 5 LYS A 178 GLY A 180 5 3 HELIX 6 6 ALA A 219 LYS A 225 1 7 HELIX 7 7 PHE A 230 GLY A 247 1 18 HELIX 8 8 CYS A 255 LYS A 265 1 11 HELIX 9 9 ASN A 275 LEU A 286 1 12 HELIX 10 10 GLU A 298 ASN A 301 5 4 HELIX 11 11 ASP A 302 SER A 307 1 6 HELIX 12 12 PRO A 315 THR A 320 5 6 SHEET 1 A 6 VAL A 43 ASP A 46 0 SHEET 2 A 6 ARG A 51 GLY A 60 -1 O TYR A 53 N LEU A 44 SHEET 3 A 6 LYS A 66 ASP A 72 -1 O CYS A 67 N GLY A 60 SHEET 4 A 6 VAL A 78 PRO A 85 -1 O PHE A 79 N ILE A 70 SHEET 5 A 6 PHE A 125 LEU A 130 -1 O LEU A 130 N ALA A 80 SHEET 6 A 6 PHE A 116 GLU A 121 -1 N PHE A 120 O PHE A 127 SHEET 1 B 2 VAL A 172 ILE A 173 0 SHEET 2 B 2 THR A 199 LYS A 200 -1 O THR A 199 N ILE A 173 SHEET 1 C 2 LEU A 182 LEU A 184 0 SHEET 2 C 2 VAL A 190 ILE A 192 -1 O LYS A 191 N PHE A 183 LINK NE2 HIS A 93 ZN ZN A 401 1555 1555 2.28 LINK SG CYS A 212 ZN ZN A 401 1555 1555 2.19 LINK ZN ZN A 401 O HOH A 526 1555 1555 2.45 SITE 1 AC1 5 HIS A 93 CYS A 212 CYS A 255 LEU A 256 SITE 2 AC1 5 HOH A 526 SITE 1 AC2 6 LYS A 178 LEU A 179 GLY A 180 ASN A 216 SITE 2 AC2 6 TYR A 217 HOH A 620 SITE 1 AC3 15 ARG A 57 PHE A 58 LEU A 59 CYS A 67 SITE 2 AC3 15 GLU A 69 LYS A 82 VAL A 114 LEU A 130 SITE 3 AC3 15 GLU A 131 CYS A 133 ARG A 134 ARG A 136 SITE 4 AC3 15 PHE A 183 HOH A 501 HOH A 610 CRYST1 66.649 66.649 153.960 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015004 0.008663 0.000000 0.00000 SCALE2 0.000000 0.017325 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006495 0.00000